- SNS-101 demonstrated a favorable pharmacokinetic profile, enhanced anti-tumor effects in combination with anti-PD-1 antibodies and a significantly improved cytokine release profile as compared to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results